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Abstract
Background: Paragangliomas occur most commonly in head and neck region and much less
frequently, they are found in the retroperitoneum. Composite paraganglioma-ganglioneuroma of
the retroperitoneum is very rare.
Case presentation: We present an unusual case of retroperitoneal composite paraganglioma-
ganglioneuroma discovered on computed tomography in a 63-year-old female patient. Routine
hematological examination and biochemical tests were within normal limits. Plasma adrenaline was
0.042 ng/ml, plasma noradrenaline 0.341 ng/ml, and plasma dopamine <0.01 ng/ml. An abdominal
contrast-enhanced CT scan and magnetic resonance imaging revealed a 6.5 cm heterogeneous
retroperitoneal mass with a cystic component. The retroperitoneal tumor accumulated 131I-
Metaiodobenzylguanidine (131I-MIBG) 48 hours after radioisotope injection. Under the diagnosis of
paraganglioma in the retroperitoneum, the patient underwent surgery. The resected tumor (6.5 ×
5 × 3 cm) was solid and easily removed en bloc. The cut surface of the tumor and histology revealed
two different components in the tumor: paraganglioma centrally and ganglioneuroma on the
periphery. She remains disease-free 18 months after surgery.
Conclusion:  This case reminds us that neuroendocrine tumor should be included in the
differential diagnosis of a retroperitoneal mass although composite paraganglioma-ganglioneuroma
in the retroperitoneum is very rare.
Background
Pheochromocytomas arising from outside the adrenal
glands are called paragangliomas [1] and constitute a rel-
atively rare disease, arising from undifferentiated cells of
the primitive neural crest [2,3]. Paragangliomas occur
most commonly in head and neck region [4], and much
less frequently, they are found in the retroperitoneum [3].
Extraadrenal paragangliomas, which account for 5-10% of
these tumors, are found in the retroperitoneum, thorax,
and urinary bladder [5]; composite tumor of the retroper-
itoneum is rare. To our knowledge, at least 4 cases of com-
posite paraganglioma-ganglioneuroma in the urinary
bladder have been reported [5-7]; however, there have
been only few reports of retroperitoneal composite para-
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ganglioma-ganglioneuroma. Herein, we report an unu-
sual case of composite paraganglioma-ganglioneuroma in
the retroperitoneum successfully treated with surgery.
Case presentation
The patient was a 63-year-old-woman, 158 cm tall and
weighing 62 kg. She was admitted to our hospital for left
femoral shaft fracture. She underwent an abdominal con-
trast-enhanced CT scan because she developed left leg
edema and was suspected of suffering deep vein thrombo-
sis of the lower extremity, and a large retroperitoneal mass
was discovered. She had no abdominal symptoms, had
been in good health, and had no specific family, past
medical, or drug history. She had not complained of
headache and had no history of hypertension. Routine
hematological examination and biochemical tests were
within normal limits. Plasma adrenaline was 0.042 ng/ml
[normal range (NR): <0.07], plasma noradrenaline 0.341
ng/ml (NR: 0.06-0.46), and plasma dopamine <0.01 ng/
ml (NR: <0.014). Regarding tumor markers, carbohydrate
antigen 19-9, carcinoembryonic antigen (CEA) and alpha
fetoprotein (AFP) were all negative. An abdominal con-
trast-enhanced CT scan (Fig. 1) and magnetic resonance
imaging (MRI) (Fig. 2) revealed a 6.5 cm heterogeneous
retroperitoneal mass with a cystic component. MRI
showed a high intensity tumor with signal intensity
greater than that of the liver and central higher signal
intensity on T2-weighted images. 131I-Metaiodobenzyl-
guanidine (131I-MIBG) scintigraphic scan tomography
was performed and the retroperitoneal tumor accumu-
lated 131I-MIBG 48 hours after radioisotope injection (Fig.
3). Her deep vein thrombosis seemed to be caused by con-
gestion and movement limit due to bone fracture and had
no connection with retroperitoneal mass because her leg
edema improved before abdominal surgery. Under the
diagnosis of paraganglioma in the retroperitoneum, the
patient underwent surgery. The resected tumor (6.5 × 5 ×
3 cm) was solid and easily removed en bloc. The tumor
An abdominal contrast-enhanced CT scan incidentally dem- onstrated a heterogeneous mass, 6.5 cm in diameter, with  cystic lesion in the retroperitoneum Figure 1
An abdominal contrast-enhanced CT scan inciden-
tally demonstrated a heterogeneous mass, 6.5 cm in 
diameter, with cystic lesion in the retroperitoneum. 
The tumor exhibited marked enhancement after intravenous 
administration of contrast material.
T2-weighted magnetic resonance images revealed a high  intensity tumor those signal intensity was greater than that of  the liver with central higher signal intensity Figure 2
T2-weighted magnetic resonance images revealed a 
high intensity tumor those signal intensity was 
greater than that of the liver with central higher sig-
nal intensity.
131I-Metaiodobenzylguanidine (131I-MIBG) scintigraphic scan  tomography showed 131I-MIBG accumulation in the retro- peritoneal tumor Figure 3
131I-Metaiodobenzylguanidine (131I-MIBG) scinti-
graphic scan tomography showed 131I-MIBG accumu-
lation in the retroperitoneal tumor.World Journal of Surgical Oncology 2009, 7:81 http://www.wjso.com/content/7/1/81
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appeared grossly encapsulated on its external surface (Fig.
4). The cut surface showed two distinct components:
brown-red lesion with a cyst and a whitish area account-
ing for 10% of the tumor (Fig. 5, Fig. 6A). The tumor had
no necrosis or hemorrhage. Histological examination of
the brown-red lesion with a cyst revealed well-defined
nests of neoplastic cells containing finely granular cyto-
plasm and enlarged nuclei referred to as 'Zellballen' (Fig.
6B). Several tumor cells had eosinophilic hyaline globules
in the cytoplasm. These neoplastic cells were positive for
chromogranin A, synaptophysin and Grimelius stain. A
population of S-100-positive sustentacular cells that were
present at the peripheries of the cell nests was seen. This
lesion was diagnosed as paraganglioma. Paraganglioma
had <1% of MIB-1-positive cells. Histological examina-
tion of the whitish area revealed the proliferation of spin-
dle shaped Schwann cells and a small number of ganglion
cells, characterized by plump cytoplasm (Fig 6C). Immu-
nohistochemical staining revealed positive immunoreac-
tivity for S-100 protein in these cells. Cells of each
component were well differentiated and no mitosis was
observed. There was no evidence of malignancy. The
tumor was composed of approximately 90% paragangli-
oma and 10% ganglioneuroma. Focal interminglings of
the two components were noted; however, two compo-
nents were separated in the greater part of the tumor.
Abrupt transition of two different components of para-
ganglioma and ganglioneuroma was seen. The diagnosis,
based on these histological findings, was composite para-
ganglioma-ganglioneuroma in the retroperitoneum. The
postoperative course was uneventful and no additional
therapy was given according to informed consent. She has
been under close periodic observation and there is no evi-
dence of this disease 18 months after surgery.
Discussion
The paraganglia are widely dispersed collections of spe-
cialized neural crest cells that lie adjacent to the sympa-
thetic ganglia and plexuses throughout the body. The
paraganglionic system includes the adrenal medulla, the
chemoreceptors, vagal body, and small groups of cells
associated with the thoracic as well as intraabdominal and
retroperitoneal ganglia [8]. Tumors that arise from chro-
maffin cells of the adrenal medulla are called pheochro-
mocytomas, whereas those that occur in paraganglia at
other sites are referred to as paragangliomas [9]. Gangli-
oneuroma is a benign neoplasm composed of Schwann
cells and ganglion cells. The most affected anatomical
sites are the posterior mediastinum, retroperitoneum,
adrenal gland and head and neck soft tissue [10]. Solitary
ganglioneuromas most commonly occur in infants and
young children, slightly more often in girls than boys,
with a female-to-male ratio of about 3:1 [11]. The major-
ity is diagnosed before the patient is 10 years of age.
Paraganglioma shows marked contrast enhancement on
contrast-enhanced CT scan [12,13]. MRI can be used to
help to locate a paraganglioma; however, only about 80%
of T2-weighted MRI studies will show the characteristic
uniform high-signal-intensity image because the presence
of internal hemorrhage may reduce signal intensity [9]. In
the present case, diagnostic images obtained by contrast-
enhanced CT scan, MRI and 131I-MIBG scintigraphic scan
tomography were compatible with paraganglioma. But we
could not diagnose this tumor as composite paragangli-
oma-ganglioneuroma.
Paraganglioma-ganglioneuroma is a rare composite
tumor, and at least one case of extra-adrenal retroperito-
neal ganglioneuroma-pheochromocytoma has been
Macroscopic finding of the tumor Figure 4
Macroscopic finding of the tumor. The resected tumor, 
6.5 × 5 × 3 cm, was encapsulated on its external surface.
The cut surface showed two different components including  a brown-red lesion with a cyst and a whitish lesion (arrows) Figure 5
The cut surface showed two different components 
including a brown-red lesion with a cyst and a whitish 
lesion (arrows).World Journal of Surgical Oncology 2009, 7:81 http://www.wjso.com/content/7/1/81
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reported [14]. Usuda et al reviewed 4 patients with para-
ganglioma-ganglioneuroma in the urinary bladder [6]. All
4 patients were older than 40 years of age (range, 49-81
years), 3 of 4 patients with composite tumor were women,
and 2 patients had a symptom of headache. They reported
that it was difficult to predict the clinical behavior of com-
posite tumors. These 4 reported cases of composite para-
ganglioma-ganglioneuromas in the urinary bladder
showed no malignant features such as extra-bladder infil-
tration or metastasis. The natural history of composite
paraganglioma-ganglioneuromas remains unclear. Thus,
accumulation of long-term follow-up cases may provide
valuable prognostic information on this composite
tumor. The pathogenesis of composite paraganglioma-
ganglioneuroma also remains unknown. Although we
could not make a conclusive remark, we thought that the
tumor might be a collision tumor because two compo-
nents (paraganglioma and ganglioneuroma) were sepa-
rated in the greater part of the tumor and transitional zone
was not recognized in the present case.
It is not possible to differentiate benign from malignant
paraganglioma confidently with imaging alone. With the
exception of the presence of distant metastases, there are
no absolute criteria for malignancy in paragangliomas.
However, features more frequently noted in malignant
tumors are extraadrenal location, greater tumor weight,
confluent necrosis, and the presence of vascular invasion
and/or extensive local invasion [5]. According to Hayes et
al [15], malignant paragangliomas tend to be large and
their four cases had average diameter of 13.8 cm (range,
10.7-17.0). Thus a tumor size of larger than 10 cm may be
indicative of malignant behavior. Assessing the prolifera-
tive index seems to be important, because all of the ana-
lyzed benign tumors showed <1% of MIB-1-positive cells
[16].
In the present case, there were no histological features sug-
gesting malignancy, and MIB-1-positive cells were <1%;
however, we should be attentive to recurrence in this case.
Sclafani et al found that 11 of 22 (50%) retroperitoneal
paragangliomas metastasized to distant organs [17] and 2
of 11 (18%) patients developed their first metastases
more than 7 years after diagnosis; thus, a longer follow-up
is needed for this disease.
Retroperitoneal paraganglioma is treated in principle by
surgical resection. Composite paraganglioma-ganglioneu-
roma in the retroperitoneum is very rare. However, as
probably most of the retroperitoneal paragangliomas are
benign, it is likely that there are patients with latent retro-
peritoneal paraganglioma, which may be incidentally dis-
covered in the future as a result of advances in diagnostic
imaging, such as improved CT and MRI.
Conclusion
Although composite paraganglioma-ganglioneuroma in
the retroperitoneum is not common, the possibility of a
neuroendocrine tumor should be considered in the differ-
ential diagnosis of a retroperitoneal mass. When a large
retroperitoneal mass is incidentally found by diagnostic
imaging, it should be carefully examined and resection
should be considered, especially in patients with tumor
size of larger than 10 cm.
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Microscopic findings of the tumor Figure 6
Microscopic findings of the tumor. (A) Two different 
components were recognized in the tumor. (B) Histological 
examination of the brown-red lesion with a cyst demonstrat-
ing a nest of neoplastic cells (Zellballen) containing finely 
granular cytoplasm and enlarged nuclei. (HE stain × 200). (C) 
The whitish lesion revealed the intersecting bundles of 
Schwann cells contained scattered ganglion cells. The gan-
glion cells had plump cytoplasm (HE stain × 100).Publish with BioMed Central    and   every 
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